Universal Bioenergy Inc. is an independent diversified energy company, headquartered in Irvine, California. Our common stock is presently listed on the OTC Pink Sheet Markets trading systems under the trading symbol UBRG. Universal Bioenergy Inc. was incorporated on August 13, 2004 in the State of Nevada. Our primary business focus is the production, marketing and sales of natural gas, petroleum, coal, propane and alternative energy. Through our subsidiary, we presently sell natural gas to 30 of the largest public utilities, electric power producers and local gas distribution companies that serve millions of commercial, industrial and residential customers throughout the United States. We are also engaged in the acquisition of oil and gas fields, lease acquisitions, and development of newly discovered or recently discovered oil and gas fields, re-entering existing wells, transmission and marketing of the products to our customer base. We are continuing our growth through an ongoing series of acquisitions, the most recent of which was NDR Energy Group LLC. In April 2010, we expanded into the natural gas energy market by the acquisition of a 49% stake in NDR Energy Group LLC, in Charlotte, North Carolina. NDR Energy markets natural gas, and was established in the State of Maryland on September 28, 2005. Through NDR Energy, we have contracts signed with 30 major utility companies in the United States, with strong Standard & Poor's credit ratings. Our customers include Southern California Gas Company, Pacific Gas & Electric, CenterPoint Energy Resources, Baltimore Gas & Electric, Memphis Light Gas & Water, Duke (Ohio & Kentucky), Michigan Consolidated and National Grid. Our gas suppliers include EDF Trading, Chevron Texaco, Conoco Phillips, Chesapeake Energy Marketing, and Anadarko. We plan to continue our growth by means of mergers and acquisitions of other companies in the natural gas, petroleum and alternative energy industries. This may also include liquefied natural gas (LNG), compressed natural gas (CNG), and acquisitions of patented energy technologies.
Universal Bioenergy Announces Third Quarter Financial Results – Reports Revenues of $49.90 Million
Nov 17, 2011
OTC Disclosure & News Service
Irvine, CA -
Bioenergy Announces Third Quarter Financial Results – Reports Revenues of $49.90 Million
Company’s 2011 Nine Month Revenues increased 145% over Nine Month Revenues for 2010
IRVINE, Calif., November 17, 2011 – Universal Bioenergy Inc. (Pink Sheets: UBRG), a natural and alternative energy company, announced today that it has filed its Third Quarter Form 10-Q Report for the financial results of operations, for the three and nine months ended September 30, 2011 with the Securities and Exchange Commission. The report contains the Company’s financial statements, management's discussion and analysis (MD&A), and its future plans.
The Company’s revenues for the third quarter of 2011, increased at a super growth rate. Universal generated record revenues of $49,904,114, for the nine month period ending September 30, 2011, which equals 121% of the total $41,320,647 in revenues for all of 2010. Revenues for the three and nine months ended September 30, 2011 were $13,855,882 and $49,904,114 respectively, as compared to $6,388,639 and $20,355,534 respectively for the same periods in 2010. This results in an increase in revenues of $7,467,243 or 117% and $29,548,548 or 145% for the three and nine months ended September 30, 2011, as compared to the same period for 2010.
The Company incurred losses of $529,585 for the three months ended September 30, 2011 and $522,728 for the same period in 2010. For the nine months ended September 30, 2011, the losses were $1,244,291 and $914,306 for the same period on 2010. Excluding the value of common stock that was issued for services, and interest expenses which together totaled $692,786, from the net loss of $1,244,291, would correspondingly reduce the net loss of $1,244,291 to an adjusted net loss of $551,505 for the nine month period ending September 30, 2011. Based on an adjusted net loss of $551,505, this adjusted net loss equals only 1.1% of the total revenues of $49,904,114 for the nine months period ending September 30, 2011.
The Company increased its total operating expenses for the three months ended September 30, 2011 from $536,557 for the period ending 2010, by a total of $40,198, or by 7.5%, to $576,755 for the same period in 2011. It incurred an increase in operating expenses for the nine months ended September 30, 2011, from $956,517 for the same period ending 2010 by a total of only $116,922, or by 12.2%, to $1,073,439 for the same period in 2011.
The Company’s total assets have increased by $26,040 or 1% to $3,028,622 for the period ending September 30, 2011, compared to $3,002,582 for the same period in 2010
Current liabilities increased to $3,111,992 for the nine months ended September 30, 2011, compared to $3,043,869 for the same period in 2010. Long term liabilities are $440,359 for the period ending September 30, 2011, compared to $312,119 for the period ending September 30, 2010.
Universal’s President Vince M. Guest says, “We are very pleased and excited about the continued double digit revenue growth the company is experiencing. Our revenues for the nine month period of 2011 increased 145% over our revenues for September of 2010, and we look forward to a strong finish this year. Very few companies in any industry are growing at that kind of accelerated rate. We now have contracts with 27 major electric utility companies nationwide, and we anticipate even greater revenues through our expanding customer base from the sale of natural gas, propane and oil. We are also working diligently to expand into the coal industry by our proposed acquisition in a thermal coal mining operation. That transaction is moving forward very well. We are working on a number of other strategic plans and proposals that we feel will be of great interest to, and will bring more value to our shareholders. We believe these future plans should provide us with greater access to the capital markets and help position the company for long-term growth and profitability. We will providing more details on these plans in the near future.”
The full Form 10-Q Annual Report is available for viewing on the SEC's website, and it is also available at our website at www.universalbioenergy.com Investor Relations, SEC Filings section.
About The Company
Universal Bioenergy Inc. is an alternative energy company, and intends to create and market natural and alternative energy sources including natural gas, petroleum, solar, biofuels, wind, synthetic fuels and related energy technology products. It plans to build the company into a prominent player in alternative energy.
For inquiries contact: Media Relations: Solomon Ali at 949-559-5017
- END –
Safe Harbor Statement – There are matters discussed in this media information that are forward looking statements within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934, and are subject to the safe harbor created by those rules. Such statements are only forecasts and actual events or results may differ materially from those discussed. For a discussion of important factors which could cause actual results to differ from the forward looking statements, refer to Universal Bioenergy Inc.’s most recent Form 10K Annual Report, and accounts and other SEC filings, which is on file with the SEC on their website at www.sec.gov. The full Form 10-Q Annual Report is also available at our website. The company undertakes no obligation to update publicly, or revise, forward looking statements, whether as a result of new information, future events or otherwise, except to the extent legally required.
Universal Bioenergy Inc. is an independent diversified
Top 10 Most Recent News Articles
Leo Cancer Care's Upright Radiotherapy Milestone
Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...
Continue Reading
Quay Shines in 2026 Prescription Sunglasses Lineup
Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...
Continue Reading
Fuse Oncology Showcases New iRT Workflow at ASTRO
Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...
Continue Reading
Synagro Technologies Faces Lawsuit Over Unpaid Expenses
Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...
Continue Reading
Salveo Home Care Faces Class Action Over Labor Violations
Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...
Continue Reading
Accuray, Samsung Push Boundaries with Imaging Deal
In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...
Continue Reading
AI Memory Growth Pushes Limits at GMIF2026 Summit
The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...
Continue Reading
DKS Facing Class Action Over Stock Slump Allegations
A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...
Continue Reading
Revamping Children's Radiotherapy: Leo Cancer Care's Vision
The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...
Continue Reading
IASO's FUCASO Shows Robust Results in 2026 Study
IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...
Continue ReadingTop 5 Most Recently Viewed Articles
Investors Encouraged to Join Ibotta Class Action at Gross Law Firm
Investors Urged to Take Action in Ibotta Class Action Lawsuit If you have invested in Ibotta, Inc. (NYSE: IBTA), it may be time to pay attention. Shareholders are being encouraged to take part in a class action lawsuit that seeks to address the alleged wrongdoings associated with the company's public offering. This initiative is spearheaded by The Gross Law Firm, which...
Continue Reading
TOMI Environmental Solutions Welcomes Harold W. Paul to Board
Strategic Board Appointment at TOMI Environmental Solutions TOMI Environmental Solutions, Inc. (NASDAQ: TOMZ), a key player in the realm of disinfection and decontamination technologies, recently announced an important addition to its Board of Directors. Harold W. Paul has been appointed to this role, a move that is expected to have a significant positive impact on the...
Continue Reading
MaxCyte's Innovative Collaboration with Moonlight Bio on T Cell Therapies
MaxCyte Forms Strategic Alliance with Moonlight Bio MaxCyte, Inc. (Nasdaq: MXCT), a pioneering cell-engineering organization, has recently announced a significant collaborative effort with Moonlight Bio, a Seattle-based company focused on pioneering preclinical-stage T cell therapies. This partnership will leverage MaxCyte’s advanced technologies to propel the...
Continue Reading
ZenaTech Showcases Drone Innovations and Future Strategy
Revolutionizing Drone Services and Defense Innovations VANCOUVER, British Columbia — ZenaTech, Inc. (NASDAQ: ZENA) (BMV: ZENA) (FSE: 49Q) stands at the forefront of technological solutions, focusing on the exciting realm of Drone as a Service (DaaS) as well as commercial drone developments catering to various industries. The company recently announced its participation...
Continue Reading
Lavu's CEO to Share Insights on AI and Payment Innovations
Lavu's CEO to Share Insights on AI and Payment Innovations Lavu, a trailblazer in restaurant AI platforms, is gearing up for an enlightening presentation featuring its CEO, Saleem S. Khatri. He will be a keynote speaker at an upcoming event focusing on the intersection of fintech, AI, and payment systems. A Discussion on Restaurant Operations and Payments The session,...
Continue Reading